- Report
- February 2025
- 135 Pages
Global
From €14257EUR$14,995USD£11,989GBP
- Report
- December 2024
- 70 Pages
Global
From €3798EUR$3,995USD£3,194GBP
- Report
- March 2025
- 150 Pages
Global
From €4611EUR$4,850USD£3,878GBP
- Report
- November 2024
- 84 Pages
Global
From €3500EUR$3,943USD£3,046GBP
- Report
- December 2024
- 130 Pages
Global
From €3422EUR$3,599USD£2,877GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
- Report
- July 2024
- 72 Pages
North America
From €3280EUR$3,450USD£2,758GBP
- Report
- July 2024
- 70 Pages
Africa, Middle East
From €3280EUR$3,450USD£2,758GBP
- Report
- July 2024
- 78 Pages
Europe
From €3280EUR$3,450USD£2,758GBP
- Report
- July 2024
- 78 Pages
Asia Pacific
From €3280EUR$3,450USD£2,758GBP
- Report
- March 2025
Global
From €300EUR$338USD£261GBP
- Report
- January 2024
- 150 Pages
Global
From €5657EUR$5,950USD£4,757GBP
- Report
- April 2020
- 233 Pages
Global
From €3328EUR$3,500USD£2,798GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,878GBP
- Report
- February 2020
- 120 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- November 2023
- 154 Pages
Global
From €2377EUR$2,500USD£1,999GBP
- Report
- July 2024
- 68 Pages
From €3280EUR$3,450USD£2,758GBP

The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more